Welcure Drugs & Pharmaceuticals Eyes Stock Split and Bonus – Is This a Strategic Play?

Pharma player Welcure drops hints about sweetening the pot for shareholders. Stock splits and bonus shares are on the table—but is this just financial sugar to mask bitter fundamentals?
Market watchers perk up as Welcure teases potential shareholder rewards. The move could boost liquidity—or just another case of corporate confetti to distract from real performance metrics.
Remember: When companies can't deliver organic growth, they often resort to financial engineering. Will Welcure's gambit pay off, or is this a classic 'look over here!' maneuver?